While it’s been easy to grow a bit desensitized to the seemingly unstoppable sales growth of Novo Nordisk and Eli Lilly’s | ...

For the first time, the FDA has approved a treatment for recurrent respiratory papillomatosis (RRP), a rare, chronic disease that causes benign tumors, most commonly in the voice box, and can force ...

With its domination of the indication- and brand-specific analyses, it should come as no surprise that AstraZeneca led the ...

As President Donald Trump works to move sky-high U.S. drug prices closer to those in other developed countries, Eli Lilly ...

San Diego CDMO TriLink BioTechnologies is reducing its headcount while its parent company, Maravai LifeSciences, moves ...

President Donald Trump’s announcement about tariffs on pharmaceutical goods imported to the United States is delayed. | ...

The Department of Health and Human Services (HHS) is relaunching a task force focused on the safety of childhood vaccines. | ...

Chinese authorities did not renew a conditional approval of Green Valley Pharmaceuticals’ controversial Alzheimer’s disease ...

Roughly three months after signing an executive order to streamline the | President Donald Trump has inked a new executive order calling on the HHS’ Administration for Strategic Preparedness and ...

The China-based phase 3 trial of telitacicept in primary Sjögren's syndrome (pSS) met its primary endpoint, which focused on ...

Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. | Generic ...

Sana Biotechnology, which had planned to produce drugs in-house, will instead turn to CDMOs for manufacturing and pause the ...